Penetration of Non-Adhesive Gel-like Embolic Materials During Dural Vessels Embolization According to Characteristics of Tantalum Powder
Source abstract
Abstract
Tantalum powder is included in the composition of Non-Adhesive Gel-like Embolic Materials (NAGLEMs) for X-ray opacity. The duration of X-ray opacity during embolization is primarily associated with the particle size, which differs in the most used NAGLEMs—ONYX (Medtronic) and SQUID (Balt). NAGLEMs are widely used for the embolization of branches of the middle meningeal artery (MMA) in patients with chronic subdural hematomas (CSDHs). Considering the size (5–15 microns) of the target dural vessels, we assumed that not only the viscosity of NAGLEMs, but also the size and shape of tantalum granules may be important for the penetration of these gel-like embolic agents and determine their behavior. A notable discrepancy in size was observed. The medium-sized granules in the SQUID 18 sample (0.443 ± 0.086 microns, M ± SD) were found to be approximately ten times smaller than the tantalum granules in the ONYX 18 sample (5.2 ± 0.33 microns, M ± SD).Tantalum granules in SQUID 18 have a regular spherical shape; in ONYX 18 they have an irregular angular shape. When comparing the behavior of gel-like embolic agents of the same viscosity during MMA embolization in patients with CSDHs (an average age of 62.2 ± 14.3 years) in the group where SQUID 18 (n = 8) was used, the gel-like embolic agent in dural vessels demonstrated significantly greater penetration ability compared with the group where ONYX 18 (n = 8) was used. Accordingly, not only the viscosity of NAGLEMs, but also the size and shape of tantalum granules can have a significant effect on the penetration ability of gel compositions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neurosurgical Procedures and Complications · Intracerebral and Subarachnoid Hemorrhage Research · Vascular Malformations Diagnosis and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia
Stavropol Krai State Budgetary Healthcare Institution “Stavropol Krai Clinical Hospital”, Semashko St., 1, 355030 Stavropol, Russia
Belostrov Clinic of High Technologies, Clinic Beloostrov, 1, Yukki Urban Settlement, Vsevolozhsk District, Leningrad Region, 188651 Saint Petersburg, Russia
References (52)
Show source-provided references
1. Petrov, A., Ivanov, A., Kolomin, E., Tukanov, N., Petrova, A., Rozhchenko, L., and Suvorova, J. (2023). The Advantages of Non-Adhesive Gel-like Embolic Materials in the Endovascular Treatment of Benign Hypervascularized Lesions of the Head and Neck. Gels, 9.10.20944/preprints202310.1137.v1 ↗
2. Neuroanatomy of Cranial Dural Vessels: Implications for Subdural Hematoma Embolization10.1136/neurintsurg-2020-016798 ↗
3. Petrov, A., Ivanov, A., Dryagina, N., Petrova, A., Samochernykh, K., and Rozhchenko, L. (2022). Angiogenetic Factors in Chronic Subdural Hematoma Development. Diagnostics, 12.10.3390/diagnostics12112787 ↗
4. Petrov, A., Ivanov, A., Rozhchenko, L., Petrova, A., Bhogal, P., Cimpoca, A., and Henkes, H. (2021). Endovascular Treatment of Chronic Subdural Hematomas through Embolization: A Pilot Study with a Non-Adhesive Liquid Embolic Agent of Minimal Viscosity (Squid). J. Clin. Med., 10.10.3390/jcm10194436 ↗
5. The First Experience of Endovascular Treatment of Chronic Subdural Hematomas with Non-Adhesive Embolization Materials of Various Viscosities: Squid 12 and 1810.17116/neiro20218505180 ↗
6. Petrov, A., Kashevnik, A., Haleev, M., Ali, A., Ivanov, A., Samochernykh, K., Rozhchenko, L., and Bobinov, V. (2024). AI-Based Approach to One-Click Chronic Subdural Hematoma Segmentation Using Computed Tomography Images. Sensors, 24.10.3390/s24030721 ↗
7. Risk of Recurrence of Subdural Hematoma after EMMA vs Surgical Drainage—Systematic Review and Meta-Analysis10.1177/1591019921990962 ↗
8. Embolization of the Middle Meningeal Artery in Patients with Chronic Subdural Hematoma-a Systematic Review and Meta-Analysis10.1007/s00701-020-04266-0 ↗
9. Middle Meningeal Artery Embolization Treatment of Nonacute Subdural Hematomas in the Elderly: A Multiinstitutional Experience of 151 Cases10.3171/2020.7.FOCUS20518 ↗
10. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Review of Established and Emerging Embolic Agents
11. Sioutas, G.S., Vivanco-Suarez, J., Shekhtman, O., Matache, I.-M., Salem, M.M., Burkhardt, J.-K., Srinivasan, V.M., and Jankowitz, B.T. (2023). Liquid Embolic Agents for Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: Institutional Experience with Systematic Review and Meta-Analysis. Interv. Neuroradiol., 15910199231183132.10.1177/15910199231183132 ↗
12. Embolic Agent Choice in Middle Meningeal Artery Embolization as Primary or Adjunct Treatment for Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis10.3174/ajnr.A7796 ↗
13. Middle Meningeal Artery Embolization with Liquid Embolic Agents for Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis10.1016/j.jvir.2023.05.010 ↗
14. Omura, Y., and Ishiguro, T. (2023). Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Systematic Review. Front. Neurol., 14.10.3389/fneur.2023.1259647 ↗
15. Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: An Effective Treatment with a Bright Future10.1136/jnis-2024-021602 ↗
16. Systematic Review of Current Randomised Control Trials in Chronic Subdural Haematoma and Proposal for an International Collaborative Approach10.1007/s00701-020-04218-8 ↗
17. Common Data Elements Reported on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma: An Interactive Systematic Review of Recent Trials10.1136/neurintsurg-2021-018430 ↗
18. Impact of Embolisate Penetration, Type, and Technique on Results After Standalone Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
19. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas10.1007/s00062-021-01066-6 ↗
20. The Macro and Microvasculature of the Dura Mater10.1007/BF00335317 ↗
21. New Alcohol and Onyx Mixture for Embolization: Feasibility and Proof of Concept in Both In Vitro and In Vivo Models10.1007/s00270-016-1559-z ↗
22. Kuianova, I., Chupakhin, A., Besov, A., Gorbatykh, A., Kislitsin, D., Orlov, K., and Parshin, D. (2023). Rheological Properties of Non-Adhesive Embolizing Compounds—The Key to Fine-Tuning Embolization Process-Modeling in Endovascular Surgery. Polymers, 15.10.3390/polym15041060 ↗
23. Basics and Principles in the Application of Onyx LD Liquid Embolic System in the Endovascular Treatment of Cerebral Arteriovenous Malformations10.1177/15910199050110S117 ↗
24. Endovascular Treatment of Cerebral Dural Arteriovenous Fistulas with SQUID 1210.1177/1591019920954095 ↗
25. Modern Liquid Embolization Agents Based on Polymers: Composition, Characteristics, and Areas of Application. Review10.1134/S1995421222010154 ↗
26. A Proposed Computed Tomography Contrast Agent Using Carboxybetaine Zwitterionic Tantalum Oxide Nanoparticles: Imaging, Biological, and Physicochemical Performance10.1097/RLI.0000000000000279 ↗
27. Spherical Tantalum Feed Powder for Metal Additive Manufacturing10.1016/j.mprp.2018.03.046 ↗
28. Additive Manufacturing of Tantalum—A Study of Chemical and Physical Properties of Printed Tantalum10.1016/j.mprp.2019.03.001 ↗
29. Imaging Artifacts of Liquid Embolic Agents on Conventional CT in an Experimental in Vitro Model10.3174/ajnr.A6867 ↗
30. Beam Hardening Artifacts of Liquid Embolic Agents: Comparison Between Squid and Onyx10.1136/neurintsurg-2018-014542 ↗
31. (2024, August 20). Onyx® Liquid Embolic System (Instructions for Use), Available online: https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030004c.pdf.
32. Advancements in the Development on New Liquid Embolic Agents for Use in Therapeutic Embolisation10.1039/D0TB01576H ↗
33. Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx)10.3174/ajnr.A1314 ↗
34. (2024, August 21). SQUID Liquid Embolic Agent (User Manual). Available online: https://docs.nevacert.ru/files/med_reestr_v2/23334_instruction.pdf.
35. Application of Onyx for Renal Arteriovenous Malformation With First Case Report of a Renal Hyperdense Striation Sign: A CARE-Compliant Article10.1097/MD.0000000000001658 ↗
36. Onyx Liquid Embolic System (LES) (2024, August 21). Appendix for the Instruction for Use. Available online: https://docs.nevacert.ru/files/med_reestr_v2/39314_instruction.pdf.
37. Ethylene Vinyl Alcohol Copolymer (EVOH) as a Functional Barrier against Surrogate Components Migrating from Paperboard10.1155/2019/4180708 ↗
38. Middle Meningeal Artery: Anatomy and Variations10.3174/ajnr.A6739 ↗
39. Lee, Y.M., Mattay, R.R., Haddad, A.F., Rinaldo, L., and Savastano, L. (2023). Middle Meningeal Artery Embolization with Polyvinyl Alcohol Particles in a Patient with Ophthalmic Artery Origin from Middle Meningeal Artery: Case Report and Technical Note. Interv. Neuroradiol., 15910199231188862.10.1177/15910199231188862 ↗
40. Anatomy of the Middle Meningeal Artery10.1055/s-0041-1733863 ↗
41. Clinical Importance of the Middle Meningeal Artery: A Review of the Literature10.7150/ijms.16489 ↗
42. The Middle Meningeal Artery: Branches, Dangerous Anastomoses, and Implications in Neurosurgery and Neuroendovascular Surgery10.1227/ONS.0000000000000010 ↗
43. Neurosurgical Contributions of the Swiss Surgeon, Rudolf Ulrich Krönlein—A Further Pioneer in Swiss Neurosurgery10.1007/s00701-012-1419-9 ↗
44. Toida, N. (1934). Über Die Endokranischen Furchen Der Arteria Meningea Media Bei Den Chinesen. J. Orient. Med., 13–15.
45. Über Die Endokranischen Furchen Der Arteria Meningea Media Bei Japanern
46. Uber Die Endocranischen Furchen Der Arteria Meningea Media Beim Menschen
47. Adachi, B. (1928). Das Arteriensystem Der Japaner Bd. I. A. Pulmonalis, Aorta. Arcus Volaris Profundus, Kaiserlich-japanische Universität zu Kyoto, in kommission bei “Maruzen Co.”.
48. The Endocranial Course of the Middle Meningeal Artery in American Whites and American Negroes10.1002/ajpa.1330220305 ↗
49. Angiographic Anatomy of the Middle Meningeal Artery in Relation to Chronic Subdural Hematoma Embolization10.1007/s00062-021-00996-5 ↗
50. Melnikova, G., Kuznetsova, T., Lapitskaya, V., Petrovskaya, A., Chizhik, S., Zykova, A., Safonov, V., Aizikovich, S., Sadyrin, E., and Sun, W. (2021). Nanomechanical and Nanotribological Properties of Nanostructured Coatings of Tantalum and Its Compounds on Steel Substrates. Nanomaterials, 11.10.3390/nano11092407 ↗
51. Safety and Efficacy Comparison of Embolic Agents for Middle Meningeal Artery Embolization for Chronic Subdural Hematoma10.7461/jcen.2023.E2023.04.002 ↗
52. A Novel, Non-Adhesive, Precipitating Liquid Embolic Implant with Intrinsic Radiopacity: Feasibility and Safety Animal Study10.1007/s00330-016-4463-7 ↗